Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Michael Glode

TitleProfessor-Clinical
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Biography 
    Collapse education and training
    Washington University SOM, St. LouisMS06/1972Medicine
    UT Southwestern, DallasInt. Med. Resident06/1974Medicine
    NIH, Bethesda06/1976Immunology
    Dana Farber Cancer Institute, BostonOncology Fellow06/1978Medical Oncology
    Gene Technology Institute, Helsinki06/1986Molecular Biology

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kessler ER, Su LJ, Gao D, Torkko KC, Wacker M, Anduha M, Chronister N, Maroni P, Crawford ED, Flaig TW, Glode LM, Lam ET. Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer. Integr Cancer Ther. 2018 12; 17(4):1103-1108. PMID: 30289005.
      View in: PubMed
    2. Hussain M, Tangen CM, Thompson IM, Swanson GP, Wood DP, Sakr W, Dawson NA, Haas NB, Flaig TW, Dorff TB, Lin DW, Crawford ED, Quinn DI, Vogelzang NJ, Glode LM. Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921. J Clin Oncol. 2018 May 20; 36(15):1498-1504. PMID: 29624463.
      View in: PubMed
    3. Maccini MA, Westfall NJ, Van Bokhoven A, Lucia MS, Poage W, Maroni PD, Wilson SS, Glodé LM, Arangua P, Newmark J, Steiner M, Werahera PN, Crawford ED. The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer. Prostate. 2018 05; 78(7):506-511. PMID: 29460452.
      View in: PubMed
    4. Wittmann D, Mehta A, Northouse L, Dunn R, Braun T, Duby A, An L, Arab L, Bangs R, Bober S, Brandon J, Coward M, Dunn M, Galbraith M, Garcia M, Giblin J, Glode M, Koontz B, Lowe A, Mitchell S, Mulhall J, Nelson C, Paich K, Saigal C, Skolarus T, Stanford J, Walsh T, Pollack CE. TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial. BMC Cancer. 2017 Oct 02; 17(1):664. PMID: 28969611.
      View in: PubMed
    5. Bourlon MT, Mora M, Hinojosa-Fano J, Martínez-Benitez B, Amini A, Castillejos-Molina R, Glodé LM. Man With Locally Advanced, High-Risk Prostate Cancer Asks About Adding Chemotherapy to His Treatment. Oncology (Williston Park). 2016 Jan; 30(1):94-8. PMID: 26791851.
      View in: PubMed
    6. Schlaepfer IR, Glodé LM, Hitz CA, Pac CT, Boyle KE, Maroni P, Deep G, Agarwal R, Lucia SM, Cramer SD, Serkova NJ, Eckel RH. Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts. Mol Imaging Biol. 2015 Aug; 17(4):529-38. PMID: 25561013.
      View in: PubMed
    7. Glodé LM. Progress in Prostate Cancer (at Last!). Oncology (Williston Park). 2015 Jun; 29(6):407, 414. PMID: 26091673.
      View in: PubMed
    8. Bourlon MT, Glodé LM, Crawford ED. Base of the skull metastases in metastatic castration-resistant prostate cancer. Oncology (Williston Park). 2014 Dec; 28(12):1115-6, 1124. PMID: 25510811.
      View in: PubMed
    9. Schlaepfer IR, Rider L, Rodrigues LU, Gijón MA, Pac CT, Romero L, Cimic A, Sirintrapun SJ, Glodé LM, Eckel RH, Cramer SD. Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Mol Cancer Ther. 2014 Oct; 13(10):2361-71. PMID: 25122071.
      View in: PubMed
    10. Lam ET, Glodé LM. Neoadjuvant and adjuvant hormonal and chemotherapy for prostate cancer. Hematol Oncol Clin North Am. 2013 Dec; 27(6):1189-204, viii. PMID: 24188258.
      View in: PubMed
    11. Glodé LM, Lam E. Nonseminomatous germ cell tumor of testis and interrupted treatment. Oncology (Williston Park). 2013 Aug; 27(8):822-3. PMID: 24133836.
      View in: PubMed
    12. Beer TM, Schellhammer PF, Corman JM, Glodé LM, Hall SJ, Whitmore JB, Frohlich MW, Penson DF. Quality of life after sipuleucel-T therapy: results from a randomized, double-blind study in patients with androgen-dependent prostate cancer. Urology. 2013 Aug; 82(2):410-5. PMID: 23896100.
      View in: PubMed
    13. Dorff TB, Glode LM. Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate cancer. Curr Opin Urol. 2013 Jul; 23(4):366-71. PMID: 23619581.
      View in: PubMed
    14. Yang X, Kessler E, Su LJ, Thorburn A, Frankel AE, Li Y, La Rosa FG, Shen J, Li CY, Varella-Garcia M, Glodé LM, Flaig TW. Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer. Clin Cancer Res. 2013 Jan 01; 19(1):148-57. PMID: 23172881.
      View in: PubMed
    15. Chaudhry A, Glodé LM, Gillman M, Miller RS. Trends in twitter use by physicians at the american society of clinical oncology annual meeting, 2010 and 2011. J Oncol Pract. 2012 May; 8(3):173-8. PMID: 22942812.
      View in: PubMed
    16. Marsland T, Arena F, Yeilding A, Glodé M, Ellis L, Yu J, Henderson C, Wagman L, Piver S, Minsky B, Rosen S, Poplack D, Potters L, Crawford D, Hoskins W. Perspective on...the new PSA screening recommendations. Oncology (Williston Park). 2011 Nov 15; 25(12):1183, 1187-8, 1190. PMID: 22229211.
      View in: PubMed
    17. Werahera PN, Glode LM, La Rosa FG, Lucia MS, Crawford ED, Easterday K, Sullivan HT, Sidhu RS, Genova E, Hedlund T. Proliferative tumor doubling times of prostatic carcinoma. Prostate Cancer. 2011; 2011:301850. PMID: 22096656.
      View in: PubMed
    18. Amato RJ, Glode LM, Podolnick J, Knight R, Crawford D. Phase II Study of Pomalidomide in Patients with Castration-Resistant Prostate Cancer. Cancers (Basel). 2011 Sep 02; 3(3):3449-60. PMID: 24212963.
      View in: PubMed
    19. Lam ET, La Rosa FG, Suby-Long TD, Kondo KL, Wilson S, Glodé LM, Flaig TW. A rare case of metastatic renal epithelioid angiomyolipoma. Oncology (Williston Park). 2011 Aug; 25(9):832-8. PMID: 21936445.
      View in: PubMed
    20. Clemons J, Glodé LM, Gao D, Flaig TW. Low-dose diethylstilbestrol for the treatment of advanced prostate cancer. Urol Oncol. 2013 Feb; 31(2):198-204. PMID: 21795073.
      View in: PubMed
    21. Beer TM, Bernstein GT, Corman JM, Glode LM, Hall SJ, Poll WL, Schellhammer PF, Jones LA, Xu Y, Kylstra JW, Frohlich MW. Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancer. Clin Cancer Res. 2011 Jul 01; 17(13):4558-67. PMID: 21558406.
      View in: PubMed
    22. Dorff TB, Flaig TW, Tangen CM, Hussain MH, Swanson GP, Wood DP, Sakr WA, Dawson NA, Haas NB, Crawford ED, Vogelzang NJ, Thompson IM, Glode LM. Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study. J Clin Oncol. 2011 May 20; 29(15):2040-5. PMID: 21502546.
      View in: PubMed
    23. Stinauer MA, Kavanagh BD, Schefter TE, Gonzalez R, Flaig T, Lewis K, Robinson W, Chidel M, Glode M, Raben D. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Radiat Oncol. 2011 Apr 08; 6:34. PMID: 21477295.
      View in: PubMed
    24. Flaig TW, Glodé M, Gustafson D, van Bokhoven A, Tao Y, Wilson S, Su LJ, Li Y, Harrison G, Agarwal R, Crawford ED, Lucia MS, Pollak M. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer. Prostate. 2010 Jun 01; 70(8):848-55. PMID: 20127732.
      View in: PubMed
    25. Kantoff PW, Schuetz TJ, Blumenstein BA, Glode LM, Bilhartz DL, Wyand M, Manson K, Panicali DL, Laus R, Schlom J, Dahut WL, Arlen PM, Gulley JL, Godfrey WR. Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. J Clin Oncol. 2010 Mar 01; 28(7):1099-105. PMID: 20100959.
      View in: PubMed
    26. Flaig TW, Glodé LM. Management of the side effects of androgen deprivation therapy in men with prostate cancer. Expert Opin Pharmacother. 2008 Nov; 9(16):2829-41. PMID: 18937615.
      View in: PubMed
    27. Glode LM. Metabolic syndrome and prostate cancer. Cancer. 2008 May 15; 112(10):2103-5. PMID: 18404693.
      View in: PubMed
    28. Attia S, Eickhoff J, Wilding G, McNeel D, Blank J, Ahuja H, Jumonville A, Eastman M, Shevrin D, Glode M, Alberti D, Staab MJ, Horvath D, Straus J, Marnocha R, Liu G. Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer. Clin Cancer Res. 2008 Apr 15; 14(8):2437-43. PMID: 18413835.
      View in: PubMed
    29. Flaig TW, Tangen CM, Hussain MH, Stadler WM, Raghavan D, Crawford ED, Glodé LM. Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial. J Clin Oncol. 2008 Mar 20; 26(9):1532-6. PMID: 18349405.
      View in: PubMed
    30. Tyagi A, Raina K, Singh RP, Gu M, Agarwal C, Harrison G, Glode LM, Agarwal R. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice. Mol Cancer Ther. 2007 Dec; 6(12 Pt 1):3248-55. PMID: 18089718.
      View in: PubMed
    31. Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model. Cancer Res. 2007 Nov 15; 67(22):11083-91. PMID: 18006855.
      View in: PubMed
    32. Hussain MH, MacVicar GR, Petrylak DP, Dunn RL, Vaishampayan U, Lara PN, Chatta GS, Nanus DM, Glode LM, Trump DL, Chen H, Smith DC. Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial. J Clin Oncol. 2007 Jun 01; 25(16):2218-24. PMID: 17538166.
      View in: PubMed
    33. Flaig TW, Su LJ, Harrison G, Agarwal R, Glodé LM. Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells. Int J Cancer. 2007 May 01; 120(9):2028-33. PMID: 17230508.
      View in: PubMed
    34. Flaig T, Crawford ED, Kavanagh B, Lucia S, La Rosa F, Barqawi A, Crighton F, Glodé LM. Prostate cancer in a man with multiple previous cancers. Oncology (Williston Park). 2007 Apr; 21(5):611-4. PMID: 17536345.
      View in: PubMed
    35. Flaig TW, Nordeen SK, Lucia MS, Harrison GS, Glodé LM. Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes. J Urol. 2007 Apr; 177(4):1229-37. PMID: 17382696.
      View in: PubMed
    36. Glodé LM. The case for adjuvant therapy for prostate cancer. J Urol. 2006 Dec; 176(6 Pt 2):S30-3. PMID: 17084163.
      View in: PubMed
    37. Arthur C, Flaig T, Su LJ, Denney R, Barnes F, Glodé LM. The effect of ultrasonic irradiation on doxorubicin-induced cytotoxicity in three human bladder cancer cell lines. Ultrasonics. 2007 Mar; 46(1):68-73. PMID: 17173946.
      View in: PubMed
    38. Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, Harrison GS, Pierson AS, Agarwal R, Glodé LM. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Invest New Drugs. 2007 Apr; 25(2):139-46. PMID: 17077998.
      View in: PubMed
    39. Grossman HB, Tangen CM, Cordon-Cardo C, Cote R, Waldman FM, De Vere White RW, Karnad AB, Glode M, Crawford ED. Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: a Southwest Oncology Group Study. Oncol Rep. 2006 Oct; 16(4):807-10. PMID: 16969498.
      View in: PubMed
    40. Denberg TD, Glodé LM, Steiner JF, Crawford ED, Hoffman RM. Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinoma. BJU Int. 2006 Aug; 98(2):335-40. PMID: 16879674.
      View in: PubMed
    41. Flaig TW, Barqawi A, Miller G, Kane M, Zeng C, Crawford ED, Glodé LM. A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer. Cancer. 2006 Jul 15; 107(2):266-74. PMID: 16779800.
      View in: PubMed
    42. Harrison GS, Wierman ME, Nett TM, Glode LM. Gonadotropin-releasing hormone and its receptor in normal and malignant cells. Endocr Relat Cancer. 2004 Dec; 11(4):725-48. PMID: 15613448.
      View in: PubMed
    43. Fung KY, Glode LM, Green S, Duncan MW. A comprehensive characterization of the peptide and protein constituents of human seminal fluid. Prostate. 2004 Oct 01; 61(2):171-81. PMID: 15305340.
      View in: PubMed
    44. Ziada A, Barqawi A, Glode LM, Varella-Garcia M, Crighton F, Majeski S, Rosenblum M, Kane M, Chen L, Crawford ED. The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial. Prostate. 2004 Sep 01; 60(4):332-7. PMID: 15264245.
      View in: PubMed
    45. Tyagi A, Agarwal C, Harrison G, Glode LM, Agarwal R. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages. Carcinogenesis. 2004 Sep; 25(9):1711-20. PMID: 15117815.
      View in: PubMed
    46. Qi L, Nett TM, Allen MC, Sha X, Harrison GS, Frederick BA, Crawford ED, Glode LM. Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor. Cancer Res. 2004 Mar 15; 64(6):2090-5. PMID: 15026348.
      View in: PubMed
    47. Tyagi AK, Agarwal C, Singh RP, Shroyer KR, Glode LM, Agarwal R. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells. Biochem Biophys Res Commun. 2003 Dec 26; 312(4):1178-84. PMID: 14651997.
      View in: PubMed
    48. Glode LM, Barqawi A, Crighton F, Crawford ED, Kerbel R. Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma. Cancer. 2003 Oct 15; 98(8):1643-8. PMID: 14534880.
      View in: PubMed
    49. Dhanalakshmi S, Agarwal P, Glode LM, Agarwal R. Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death. Int J Cancer. 2003 Sep 20; 106(5):699-705. PMID: 12866029.
      View in: PubMed
    50. Qi L, Nett TM, Allen MC, Sha X, Harrison GS, Frederick BA, Glode LM. GnRH-PAP hormonotoxin targets cytotoxicity to prostate cancer cell lines. Urol Res. 2003 Dec; 31(6):374-7. PMID: 13680022.
      View in: PubMed
    51. Qi L, Singh RP, Lu Y, Agarwal R, Harrison GS, Franzusoff A, Glode LM. Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line. Cancer Biol Ther. 2003 Sep-Oct; 2(5):526-31. PMID: 14614320.
      View in: PubMed
    52. Qi L, Robinson WA, Brady BM, Glode LM. Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors. Anticancer Res. 2003 Sep-Oct; 23(5A):3917-22. PMID: 14666697.
      View in: PubMed
    53. Skinner EC, Glode LM. High-risk localized prostate cancer: primary surgery and adjuvant therapy. Urol Oncol. 2003 May-Jun; 21(3):219-27. PMID: 12810210.
      View in: PubMed
    54. Bergen M, Lewis K, Chen R, Kenney T, Glode LM. Prostate cancer on the internet: impact on patients and how technology helps physicians and researchers. Clin Prostate Cancer. 2003 Mar; 1(4):227-34. PMID: 15040881.
      View in: PubMed
    55. Glodé M. Eureka moments. Pharos Alpha Omega Alpha Honor Med Soc. 2003; 66(4):43-4. PMID: 14725198.
      View in: PubMed
    56. Abouelfadel Z, Miller GJ, Glode LM, Akduman B, Donohue RE, Nedrow A, Crawford ED. High Gleason scores and lower prostate-specific antigen levels in a single institution over the past decade. Clin Prostate Cancer. 2002 Sep; 1(2):115-7. PMID: 15046702.
      View in: PubMed
    57. Whitehead RP, Lew D, Flanigan RC, Weiss GR, Roy V, Glode ML, Dakhil SR, Crawford ED. Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study. J Immunother. 2002 Jul-Aug; 25(4):352-8. PMID: 12142558.
      View in: PubMed
    58. Mazzini MJ, Glode LM. Internet oncology: increased benefit and risk for patients and oncologists. Hematol Oncol Clin North Am. 2001 Jun; 15(3):583-92. PMID: 11525299.
      View in: PubMed
    59. Olsen E, Duvic M, Frankel A, Kim Y, Martin A, Vonderheid E, Jegasothy B, Wood G, Gordon M, Heald P, Oseroff A, Pinter-Brown L, Bowen G, Kuzel T, Fivenson D, Foss F, Glode M, Molina A, Knobler E, Stewart S, Cooper K, Stevens S, Craig F, Reuben J, Bacha P, Nichols J. Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol. 2001 Jan 15; 19(2):376-88. PMID: 11208829.
      View in: PubMed
    60. Goluboff ET, Hirano D, Thrasher JB, Stark G, Miller GJ, Glodé LM. New approaches to the treatment of advanced prostate cancer. Rev Urol. 2001; 3 Suppl 2:S69-78. PMID: 16986001.
      View in: PubMed
    61. Crawford ED, Miller GJ, Labrie F, Hirano D, Batuello J, Glodé LM. Prostate cancer pathology, screening, and epidemiology. Rev Urol. 2001; 3 Suppl 2:S2-S10. PMID: 16985996.
      View in: PubMed
    62. Vaishampayan U, Glode M, Du W, Kraft A, Hudes G, Wright J, Hussain M. Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma. Clin Cancer Res. 2000 Nov; 6(11):4205-8. PMID: 11106233.
      View in: PubMed
    63. Dahn KA, Glode MP, Chan KH. Periodic fever and pharyngitis in young children: a new disease for the otolaryngologist? Arch Otolaryngol Head Neck Surg. 2000 Sep; 126(9):1146-9. PMID: 10979131.
      View in: PubMed
    64. Suh CI, Shanafelt T, May DJ, Shroyer KR, Bobak JB, Crawford ED, Miller GJ, Markham N, Glode LM. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer. Mol Cell Probes. 2000 Aug; 14(4):211-7. PMID: 10970725.
      View in: PubMed
    65. Walsh P, Gonzalez R, Dow S, Elmslie R, Potter T, Glode LM, Baron AE, Balmer C, Easterday K, Allen J, Rosse P. A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma. University of Colorado Cancer Center Clinical Trial. Hum Gene Ther. 2000 Jun 10; 11(9):1355-68. PMID: 10890744.
      View in: PubMed
    66. Hardy PA, Mazzini MJ, Schweitzer C, Lundstrom K, Glode LM. Recombinant Semliki forest virus infects and kills human prostate cancer cell lines and prostatic duct epithelial cells ex vivo. Int J Mol Med. 2000 Mar; 5(3):241-5. PMID: 10677563.
      View in: PubMed
    67. Glodé LM. Early prostate cancer diagnosis and therapy. Adv Intern Med. 2000; 45:41-64. PMID: 10635045.
      View in: PubMed
    68. Glode LM, Petrylak DP, Glode LM. Refractory disease, new horizons and patient-physician relationships. Prostate Cancer Prostatic Dis. 1999 Jan; 2(S1):19-20. PMID: 12496852.
      View in: PubMed
    69. Reid MB, Glode LM. Flutamide induced lupus. J Urol. 1998 Jun; 159(6):2098. PMID: 9598538.
      View in: PubMed
    70. Lidor YJ, Lee WE, Nilson JH, Maxwell IH, Su LJ, Brand E, Glode LM. In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines. Am J Obstet Gynecol. 1997 Sep; 177(3):579-85. PMID: 9322627.
      View in: PubMed
    71. Harrison GS, Glode LM. Current challenges of gene therapy for prostate cancer. Oncology (Williston Park). 1997 Jun; 11(6):845-50, 856; discussion 856-8, 861. PMID: 9189941.
      View in: PubMed
    72. Glodé LM. Challenges and opportunities of the Internet for medical oncology. J Clin Oncol. 1996 Jul; 14(7):2181-6. PMID: 8683253.
      View in: PubMed
    73. Walsh P, Dorner A, Duke RC, Su LJ, Glode LM. Macrophage colony-stimulating factor complementary DNA: a candidate for gene therapy in metastatic melanoma. J Natl Cancer Inst. 1995 Jun 07; 87(11):809-16. PMID: 7791230.
      View in: PubMed
    74. Glodé LM. Prostate cancer screening: a place for informed consent? Hosp Pract (Off Ed). 1994 Sep 15; 29(9):8, 11-2. PMID: 7521881.
      View in: PubMed
    75. Cook DR, Maxwell IH, Glode LM, Maxwell F, Stevens JO, Purner MB, Wagner E, Curiel DT, Curiel TJ. Gene therapy for B-cell lymphoma in a SCID mouse model using an immunoglobulin-regulated diphtheria toxin gene delivered by a novel adenovirus-polylysine conjugate. Cancer Biother. 1994; 9(2):131-41. PMID: 7812362.
      View in: PubMed
    76. Rothstein EP, Bernstein HH, Glode MP, Laussucq S, Nonenmacher J, Long SS, Hackell JG. Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines. Am J Dis Child. 1993 Aug; 147(8):854-7. PMID: 8394646.
      View in: PubMed
    77. Maxwell IH, Glode LM, Maxwell F. Expression of diphtheria toxin A-chain in mature B-cells: a potential approach to therapy of B-lymphoid malignancy. Leuk Lymphoma. 1992 Aug; 7(5-6):457-62. PMID: 1493446.
      View in: PubMed
    78. Harrison GS, Long CJ, Maxwell F, Glode LM, Maxwell IH. Inhibition of HIV production in cells containing an integrated, HIV-regulated diphtheria toxin A chain gene. AIDS Res Hum Retroviruses. 1992 Jan; 8(1):39-45. PMID: 1736939.
      View in: PubMed
    79. Mohler JL, Gomella LG, Crawford ED, Glode LM, Zippe CD, Fair WR, Marshall ME. Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma. Prostate. 1992; 20(2):123-31. PMID: 1549551.
      View in: PubMed
    80. Kendall SK, Saunders TL, Jin L, Lloyd RV, Glode LM, Nett TM, Keri RA, Nilson JH, Camper SA. Targeted ablation of pituitary gonadotropes in transgenic mice. Mol Endocrinol. 1991 Dec; 5(12):2025-36. PMID: 1665205.
      View in: PubMed
    81. Fisher KS, Maxwell IH, Murphy JR, Collier J, Glode LM. Construction and expression of plasmids containing mutated diphtheria toxin A-chain-coding sequences. Infect Immun. 1991 Oct; 59(10):3562-5. PMID: 1894362.
      View in: PubMed
    82. Maxwell IH, Glode LM, Maxwell F. Expression of the diphtheria toxin A-chain coding sequence under the control of promoters and enhancers from immunoglobulin genes as a means of directing toxicity to B-lymphoid cells. Cancer Res. 1991 Aug 15; 51(16):4299-304. PMID: 1868451.
      View in: PubMed
    83. Harrison GS, Maxwell F, Long CJ, Rosen CA, Glode LM, Maxwell IH. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells. Hum Gene Ther. 1991; 2(1):53-60. PMID: 1863640.
      View in: PubMed
    84. Erickson PF, Maxwell IH, Su LJ, Baumann M, Glode LM. Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes. Biochem J. 1990 Jul 15; 269(2):335-40. PMID: 2201285.
      View in: PubMed
    85. Glode LM, Shannon JM, Malik N, Nett T. Protection of rat spermatogenic epithelium from damage induced by procarbazine chemotherapy. Br J Cancer. 1990 Jul; 62(1):61-4. PMID: 2117966.
      View in: PubMed
    86. Hemilä H, Glode LM, Palva I. Production of diphtheria toxin CRM228 in B. subtilis. FEMS Microbiol Lett. 1989 Nov; 53(1-2):193-8. PMID: 2515098.
      View in: PubMed
    87. Klein CE, Roberts B, Holcenberg J, Glode LM. Cystathionine metabolism in neuroblastoma. Cancer. 1988 Jul 15; 62(2):291-8. PMID: 3383129.
      View in: PubMed
    88. Breitman ML, Clapoff S, Rossant J, Tsui LC, Glode LM, Maxwell IH, Bernstein A. Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice. Science. 1987 Dec 11; 238(4833):1563-5. PMID: 3685993.
      View in: PubMed
    89. Maxwell F, Maxwell IH, Glode LM. Cloning, sequence determination, and expression in transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain. Mol Cell Biol. 1987 Apr; 7(4):1576-9. PMID: 3110596.
      View in: PubMed
    90. Glode LM, Smith JA. Long-term suppression of luteinizing hormone, follicle-stimulating hormone and testosterone by daily administration of leuprolide. J Urol. 1987 Jan; 137(1):57-60. PMID: 3098990.
      View in: PubMed
    91. Glode MP, Brogden RL, Joffe LS, Wiggins JW. Microbial toxins and Kawasaki disease. Prog Clin Biol Res. 1987; 250:81-6. PMID: 3423084.
      View in: PubMed
    92. Maxwell IH, Maxwell F, Glode LM. Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: possible strategy for inducing cancer cell suicide. Cancer Res. 1986 Sep; 46(9):4660-4. PMID: 3460697.
      View in: PubMed
    93. Montgomery RR, Kunicki TJ, Glode LM. Use of monoclonal antibody to increase the sensitivity and specificity of precipitating immunoassays and cell surface binding immunoassays. Methods Enzymol. 1986; 121:702-17. PMID: 3724493.
      View in: PubMed
    94. Thomas MR, Robinson WA, Mughal TI, Morton N, Glode LM. Recovery of blood and bone marrow stem cells following intense chemotherapy and autologous bone marrow transplantation. Oncology. 1986; 43(5):273-7. PMID: 3531952.
      View in: PubMed
    95. Braunschweiger PG, Glode LM, Maring EM, Machus K, Reynolds K. Biological implications of androgen dependent changes in proton-NMR relaxation times in rat ventral prostate. Prostate. 1986; 9(3):283-94. PMID: 3095803.
      View in: PubMed
    96. Glode LM. The biology of gonadotropin-releasing hormone and its analogs. Urology. 1986 Jan; 27(1 Suppl):16-20. PMID: 3079934.
      View in: PubMed
    97. Mughal TI, Glode LM, Braun TJ, Klingensmith W, Geier JM, Kindt GW. Phase I clinical trial of intracarotid bis-chloroethylnitrosourea (BCNU) and 2' dioxy-5-fluorouridine (FUDR) in malignant astrocytomas. J Neurooncol. 1986; 3(4):291-6. PMID: 2937887.
      View in: PubMed
    98. Glode LM, Smith JA. LHRH. JAMA. 1985 Jul 26; 254(4):506-7. PMID: 3892064.
      View in: PubMed
    99. Ambrosino DM, Glode MP, Williams CL, Siber GR. Antibody response of infants to Haemophilus influenzae type b capsular polysaccharide combined with Bordetella pertussis. J Infect Dis. 1985 Jun; 151(6):1174. PMID: 2860187.
      View in: PubMed
    100. Garnick MB, Glode LM, Smith JA, Max DT. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate. Br J Clin Pract Suppl. 1985 Mar; 37:8-12, 20-4. PMID: 3931665.
      View in: PubMed
    101. Garnick MB, Glode LM, Smith JA, Max DT. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate. Br J Clin Pract. 1985 Feb; 39(2):73-6. PMID: 3921047.
      View in: PubMed
    102. Smith JA, Glode LM, Wettlaufer JN, Stein BS, Glass AG, Max DT, Anbar D, Jagst CL, Murphy GP. Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate. Urology. 1985 Feb; 25(2):106-14. PMID: 3918369.
      View in: PubMed
    103. Santen RJ, English H, Rohner T, Drago J, Lipton A, Harvey H, Simmonds M, Boucher A, Glode LM, Wettlaufer J, et al. Androgen depletion/repletion in combination with chemotherapy: strategy for secondary treatment of metastatic prostatic cancer. Prog Clin Biol Res. 1985; 185A:359-71. PMID: 4034580.
      View in: PubMed
    104. Leuprolide Study Group (LM Glode and MB Garnick Writing Committee). Leuprolide versus diethylstilbestrol for metastatic prostate cancer. New England Journal of Medicine. 1984; 20(311):1281-1286.
    105. Lepow ML, Peter G, Glode MP, Daum RS, Calnen G, Knight KM, Mayer D, Kuo JS, Lui NS. Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination. J Infect Dis. 1984 Jun; 149(6):950-5. PMID: 6376656.
      View in: PubMed
    106. Mughal TI, Robinson WA, Thomas MR, Glode LM. Malignant melanoma and BCNU. Clin Oncol. 1984 Jun; 10(2):185. PMID: 6734009.
      View in: PubMed
    107. Glode LM, Robinson J, Horwitz LD. Scrotal hypothermia and testicular blood flow in the dog. Absence of thermal regulation. J Androl. 1984 May-Jun; 5(3):227-9. PMID: 6746413.
      View in: PubMed
    108. Manni A, Santen RJ, Boucher AE, Lipton A, Harvey H, Drago J, Rohner T, Haagensen D, Glode M, Santner SJ. Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation. Anticancer Res. 1984 May-Jun; 4(3):141-4. PMID: 6380398.
      View in: PubMed
    109. Thomas MR, Robinson WA, Mughal TI, Glode LM. Tumor lysis syndrome following VP-16-213 in chronic myeloid leukemia in blast crisis. Am J Hematol. 1984 Feb; 16(2):185-8. PMID: 6582781.
      View in: PubMed
    110. Santen RJ, Demers LM, Max DT, Smith J, Stein BS, Glode LM. Long term effects of administration of a gonadotropin-releasing hormone superagonist analog in men with prostatic carcinoma. J Clin Endocrinol Metab. 1984 Feb; 58(2):397-400. PMID: 6420439.
      View in: PubMed
    111. Thomas MR, Robinson WA, Dantas M, Koeppler H, Drebing C, Glode LM. Autologous marrow transplantation for patients with chronic myelogenous leukemia (CML) in blast crisis. Am J Hematol. 1984 Feb; 16(2):105-12. PMID: 6364801.
      View in: PubMed
    112. Chitambar CR, Robinson WA, Glode LM. Familial leukemia and aplastic anemia associated with monosomy 7. Am J Med. 1983 Nov; 75(5):756-62. PMID: 6638045.
      View in: PubMed
    113. Gould SF, Powell D, Nett T, Glode LM. A rat model for chemotherapy-induced male infertility. Arch Androl. 1983 Oct; 11(2):141-50. PMID: 6639202.
      View in: PubMed
    114. Dantas ME, Brown JP, Thomas MR, Robinson WA, Glode LM. Detection of melanoma cells in bone marrow using monoclonal antibodies. A comparison of fluorescence activated cell sorting (FACS) and conventional immunofluorescence (IF). Cancer. 1983 Sep 15; 52(6):949-53. PMID: 6349783.
      View in: PubMed
    115. Link D, Drebing C, Glode LM. Cystathionase: a potential cytoplasmic marker of hematopoietic differentiation. Blut. 1983 Jul; 47(1):31-9. PMID: 6860801.
      View in: PubMed
    116. Halsey NA, Johansen TL, Bowman LC, Glode MP. Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model. Infect Immun. 1983 Mar; 39(3):1196-200. PMID: 6601621.
      View in: PubMed
    117. Thomas MR, Robinson WA, Glode LM, Dantas ME, Koeppler H, Morton N, Sutherland J. Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Preliminary results--Phase I study. Am J Clin Oncol. 1982 Dec; 5(6):611-22. PMID: 6762087.
      View in: PubMed
    118. Daum RS, Glode MP. Rifampin prophylaxis against H. flu type b spread - is it valid? Hosp Pract (Off Ed). 1982 Nov; 17(11):124A-C, 124K-L, 124N-P. PMID: 6813223.
      View in: PubMed
    119. Glode LM, Robinson WA, Hartmann DW, Klein JJ, Thomas MR, Morton N. Autologous bone marrow transplantation in the therapy of small cell carcinoma of the lung. Cancer Res. 1982 Oct; 42(10):4270-5. PMID: 6286106.
      View in: PubMed
    120. Glode LM, Epstein A, Smith CG. Reduced gamma-cystathionase protein content in human malignant leukemia cell lines as measured by immunoassay with monoclonal antibody. Cancer Res. 1981 Jun; 41(6):2249-54. PMID: 6786735.
      View in: PubMed
    121. Glode LM, Robinson J, Gould SF. Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet. 1981 May 23; 1(8230):1132-4. PMID: 6112490.
      View in: PubMed
    122. Hartmann DW, Robinson WA, Morton NJ, Mangalik A, Glode LM. High-dose nitrogen mustard (HN2) with autologous nonfrozen bone marrow transplantation in advanced malignant melanoma. A phase I trial. Blut. 1981 Apr; 42(4):209-20. PMID: 7013856.
      View in: PubMed
    123. Glode LM, Kriegler MP, Livingston DM. Cysteine auxotrophy of human leukemic lymphoblasts is associated with decreased amounts of intracellular cystathionase protein. Biochemistry. 1981 Mar 03; 20(5):1306-11. PMID: 7225330.
      View in: PubMed
    124. Halsey NA, Korock C, Johansen TL, Glode MP. Intralitter transmission of haemophilus influenzae type b in infant rats and rifampin eradication of nasopharyngeal colonization. J Infect Dis. 1980 Nov; 142(5):739-43. PMID: 6970234.
      View in: PubMed
    125. Ryan JL, Glode LM, Rosenstreich DL. Lack of responsiveness of C3H/HeJ macrophages to lipopolysaccharide: the cellular basis of LPS-stimulated metabolism. J Immunol. 1979 Mar; 122(3):932-5. PMID: 376709.
      View in: PubMed
    126. Wahl LM, Rosenstreich DL, Glode LM, Sandberg AL, Mergenhagen SE. Defective prostaglandin synthesis by C3H/HeJ mouse macrophages stimulated with endotoxin preparations. Infect Immun. 1979 Jan; 23(1):8-13. PMID: 422236.
      View in: PubMed
    127. Glode MP, Lewin EB, Sutton A, Le CT, Gotschlich EC, Robbins JB. Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers. J Infect Dis. 1979 Jan; 139(1):52-9. PMID: 108338.
      View in: PubMed
    128. Ensminger WD, Rosowsky A, Raso V, Levin DC, Glode M, Come S, Steele G, Frei E. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Res. 1978 Nov; 38(11 Pt 1):3784-92. PMID: 151583.
      View in: PubMed
    129. Rosenstreich DL, Glode LM, Mergenhagen SE. Action of endotoxin on lymphoid cells. J Infect Dis. 1977 Aug; 136 Suppl:S239-45. PMID: 302290.
      View in: PubMed
    130. Glode MP, Sutton A, Robbins JB, McCracken GH, Gotschlich EC, Kaijser B, Hanson LA. Neonatal meningitis due of Escherichia coli K1. J Infect Dis. 1977 Aug; 136 Suppl:S93-7. PMID: 330780.
      View in: PubMed
    131. Moxon ER, Glode MP, Sutton A, Robbins JB. The infant rat as a model of bacterial meningitis. J Infect Dis. 1977 Aug; 136 Suppl:S186-90. PMID: 330777.
      View in: PubMed
    132. Glode LM, Jacques A, Mergenhagen SE, Rosenstreich DL. Resistance of macrophages from C3H/HeJ mice to the in vitro cytotoxic effects of endotoxin. J Immunol. 1977 Jul; 119(1):162-6. PMID: 326955.
      View in: PubMed
    133. Glode MP, Sutton A, Moxon ER, Robbins JB. Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1. Infect Immun. 1977 Apr; 16(1):75-80. PMID: 326679.
      View in: PubMed
    134. Glode MP, Robbins JB, Liu TY, Gotschlich EC, Orskov I, Orskov F. Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J Infect Dis. 1977 Jan; 135(1):94-104. PMID: 64575.
      View in: PubMed
    135. Glode LM, Rosenstreich DL. Genetic control of B cell activation by bacterial lipopolysaccharide is mediated by multiple distinct genes or alleles. J Immunol. 1976 Dec; 117(6):2061-6. PMID: 792337.
      View in: PubMed
    136. Glode LM, Mergenhagen SE, Rosenstreich DL. Significant contribution of spleen cells in mediating the lethal effects of endotoxin in vivo. Infect Immun. 1976 Sep; 14(3):626-30. PMID: 965087.
      View in: PubMed
    137. Glode LM, Scher I, Osborne B, Rosenstreich DL. Cellular mechanism of endotoxin unresponsiveness in C3H/HeJ mice. J Immunol. 1976 Feb; 116(2):454-61. PMID: 129492.
      View in: PubMed
    138. Rosenstreich DL, Glode LM. Difference in B cell mitogen responsiveness between closely related strains of mice. J Immunol. 1975 Sep; 115(3):777-80. PMID: 239063.
      View in: PubMed
    Glode's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (640) concept(s)
    _
    Co-Authors Expand Description
    See all (31) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2019 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)